NCT01323894

Brief Summary

The first year purpose: The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 28, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2011

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

June 17, 2016

Status Verified

June 1, 2016

Enrollment Period

1 year

First QC Date

March 24, 2011

Last Update Submit

June 15, 2016

Conditions

Primary Disease

Outcome Measures

Primary Outcomes (1)

  • Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling/Hydroxyapatite Nanoparticles--Comparisons between Non-viral and Viral administration in Tissue Engineered Bone Regeneration

    August 2011-July 2013

    2 years

Eligibility Criteria

Age10 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients require surgery ner iliac or abdomen areas

You may qualify if:

  • age above 10 years old
  • The patients require surgery ner iliac or abdomen areas

You may not qualify if:

  • age below 10 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical Universty Hospital

Taichung, 404, Taiwan

Location

Study Officials

  • Sopha Chia-Ning Chang, M.D. Ph.D.

    China Medical University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2011

First Posted

March 28, 2011

Study Start

August 1, 2011

Primary Completion

August 1, 2012

Study Completion

July 1, 2013

Last Updated

June 17, 2016

Record last verified: 2016-06

Locations

TW(1)